NAS:ARPO (USA) Also Trade In: Germany

Aerpio Pharmaceuticals Inc $ 1.34 0 (0%)

Volume:
449,004
Avg Vol (1m):
1,230,232
Market Cap $:
56.37 Mil
Enterprise Value $:
11.63 Mil
P/E (TTM):
0.00
P/B:
1.28
Warning! GuruFocus has detected 1 Medium warning sign with ARPO. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for ARPO (Aerpio Pharmaceuticals Inc) from 2017 to Oct 31 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Aerpio Pharmaceuticals stock (ARPO) PE ratio as of Oct 31 2020 is 0. More Details

Aerpio Pharmaceuticals PE Ratio (TTM) Chart

EMBED

Aerpio Pharmaceuticals PE Ratio (TTM) Historical Data

Total 839
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10
Aerpio Pharmaceuticals PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2020-10-310.0 2020-08-310.0
2020-10-300.0 2020-08-280.0
2020-10-290.0 2020-08-270.0
2020-10-280.0 2020-08-260.0
2020-10-270.0 2020-08-250.0
2020-10-260.0 2020-08-240.0
2020-10-230.0 2020-08-210.0
2020-10-220.0 2020-08-200.0
2020-10-210.0 2020-08-190.0
2020-10-200.0 2020-08-180.0
2020-10-190.0 2020-08-170.0
2020-10-160.0 2020-08-140.0
2020-10-150.0 2020-08-130.0
2020-10-140.0 2020-08-120.0
2020-10-130.0 2020-08-110.0
2020-10-120.0 2020-08-100.0
2020-10-090.0 2020-08-070.0
2020-10-080.0 2020-08-060.0
2020-10-070.0 2020-08-050.0
2020-10-060.0 2020-08-040.0
2020-10-050.0 2020-08-030.0
2020-10-020.0 2020-07-310.0
2020-10-010.0 2020-07-300.0
2020-09-300.0 2020-07-290.0
2020-09-290.0 2020-07-280.0
2020-09-280.0 2020-07-270.0
2020-09-250.0 2020-07-240.0
2020-09-240.0 2020-07-230.0
2020-09-230.0 2020-07-220.0
2020-09-220.0 2020-07-210.0
2020-09-210.0 2020-07-200.0
2020-09-180.0 2020-07-170.0
2020-09-170.0 2020-07-160.0
2020-09-160.0 2020-07-150.0
2020-09-150.0 2020-07-140.0
2020-09-140.0 2020-07-130.0
2020-09-110.0 2020-07-100.0
2020-09-100.0 2020-07-090.0
2020-09-090.0 2020-07-080.0
2020-09-080.0 2020-07-070.0
2020-09-070.0 2020-07-060.0
2020-09-040.0 2020-07-030.0
2020-09-030.0 2020-07-020.0
2020-09-020.0 2020-07-010.0
2020-09-010.0 2020-06-300.0

Aerpio Pharmaceuticals PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Biotechnology » NAICS : 325412 NAICS : 2834
Traded in other countries 335.Germany ARPO.USA
Address 9987 Carver Road, Cincinnati, OH, USA, 45242
Aerpio Pharmaceuticals Inc is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The company's product AKB-9778, is a Tie2 activator being developed for the treatment of diabetic eye disease. Other products under the pipeline are cc-1536 and c-4924.